Abstract | BACKGROUND: Effective methods to deliver therapeutic genes to solid tumors and improve their bioavailability are the main challenges of current medical research on gene therapy. The development of efficient non-viral gene vector with tumor-targeting has very important application value in the field of cancer therapy. Proteolipid integrated with tumor-targeting potential of functional protein and excellent gene delivery performance has shown potential for targeted gene therapy. RESULTS: Herein, we prepared transferrin-modified liposomes (Tf-PL) for the targeted delivery of acetylcholinesterase (AChE) therapeutic gene to liver cancer. We found that the derived Tf-PL/AChE liposomes exhibited much higher transfection efficiency than the commercial product Lipo 2000 and shown premium targeting efficacy to liver cancer SMMC-7721 cells in vitro. In vivo, the Tf-PL/AChE could effectively target liver cancer, and significantly inhibit the growth of liver cancer xenografts grafted in nude mice by subcutaneous administration. CONCLUSIONS: This study proposed a transferrin-modified proteolipid-mediated gene delivery strategy for targeted liver cancer treatment, which has a promising potential for precise personalized cancer therapy.
|
Authors | Kai Wang, Fusheng Shang, Dagui Chen, Tieliu Cao, Xiaowei Wang, Jianpeng Jiao, Shengli He, Xiaofei Liang |
Journal | Journal of nanobiotechnology
(J Nanobiotechnology)
Vol. 19
Issue 1
Pg. 31
(Jan 22 2021)
ISSN: 1477-3155 [Electronic] England |
PMID | 33482834
(Publication Type: Journal Article)
|
Chemical References |
- Liposomes
- Transferrin
- Acetylcholinesterase
|
Topics |
- Acetylcholinesterase
(genetics)
- Animals
- Cell Line, Tumor
- Female
- Gene Transfer Techniques
- Genetic Therapy
- Humans
- Liposomes
(chemistry)
- Liver Neoplasms
(genetics, therapy)
- Mice, Inbred BALB C
- Mice, Nude
- Plasmids
(administration & dosage, genetics, therapeutic use)
- Transfection
- Transferrin
(chemistry)
|